NCT07545837
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Adenocarcinoma, Follicular
Explore clinical trials studying Adenocarcinoma, Follicular. Study availability and eligibility vary by location and protocol.
53 public trials
6 recruiting studies
Adenocarcinoma, Follicular trial results
NCT06959641
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +32 more
- Locations
-
- Harbor-UCLA Medical Center Torrance, California, United States
- Northwestern University Chicago, Illinois, United States
Recruiting
Studies on Tumors of the Thyroid
NCT00001160
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT05575440
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +14 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT06440850
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05668962
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +17 more
- Locations
-
- MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States
Not yet recruiting
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
NCT07529080
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +33 more
- Locations
-
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
Active, not recruiting
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
NCT03914300
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
Active, not recruiting
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
NCT01398085
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
- Locations
-
- Belfast Health and Social Care Trust Belfast, United Kingdom
- University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
- University Hospitals Sussex NHS Foundation Trust Brighton, United Kingdom
- University Hospital Bristol NHS Foundation Trust Bristol, United Kingdom
Active, not recruiting
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
NCT02152995
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +23 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States